Head-to-head · WeighScore
AgelessRx vs GoodRx
By GLP-1 ScorecardUpdated
Score comparison
AgelessRx has the higher recorded score — 84.3/100 to 69.6/100.
AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AgelessRx | GoodRx |
|---|---|---|
| WeighScore | 84.3/100 | 69.6/100 |
| Grade | B | C |
| Site position | #17 | #132 |
| Semaglutide | Not verified (current medication-specific quote required) | Wegovy pill from $149 at 1.5 mg; injection $199 for two qualifying fills then $349. Separate $39/mo care fee if subscribed; dose/offer conditions apply. |
| Tirzepatide | Microdose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required | Zepbound KwikPen advertised from $299; dose-specific and 28-day supply/refill conditions apply. Separate $39/mo care fee if subscribed; confirm pharmacy quote. |
| Coverage | Advertises US service; confirm treatment-specific state availability | Prescription savings at participating U.S. pharmacies; Care Direct weight-loss prescribing excludes Alabama and Louisiana. Confirm the specific treatment and pharmacy. |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #17 · B
Strengths
- Conventional and lower-dose GLP-1 programs advertised
- Wegovy pens and oral-tablet consultations advertised
- Continuing messaging and check-ins advertised
What to consider
- Conventional medication-specific monthly quotes not verified
- Microdose introduction renews as a two-month charge
- Branded medication has a separate pharmacy bill
- Treatment-specific state eligibility and assigned dispenser need confirmation
Site position #132 · C
Strengths
- Free prescription discounts can be used without purchasing the weight-loss care subscription
- Current Care Direct menu names oral Wegovy, injectable Wegovy/HD, Foundayo tablets and Zepbound KwikPen
- Publishes a separate $39 monthly care fee rather than presenting it as the medication price
- Official terms name possible medical groups and dispensing pharmacies; the guide explains pharmacy selection
What to consider
- Medication is extra; dose offers do not establish continuing cost. Foundayo and Zepbound self-pay card savings end December 31, 2026
- The Zepbound page has an inconsistent 10 mg lowest-dose label; confirm device, strength and selected quote
- Support and terms differ on the initial care-charge trigger; renewals are automatic and cancellation requires at least one day’s notice
- Care Direct weight-loss treatment excludes Alabama and Louisiana, and the guide says no insurance prior-authorization submissions
- Actual dispensing branch, lab costs and refill timing still require confirmation; canceling does not guarantee a refund
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.